Norway· NO-ID_E7E84F46-3DEC-48A8-A057-0773D240BB37
Fabhalta
A iptacopan product containing iptacopan, registered in Norway by Novartis Europharm Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Iptacopan is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AJ08 (iptacopan), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Iptacopan · ATC L04AJ08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of iptacopan costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Iptacopan · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$1117.78
The record
At a glance
FEST (Norway)- Active substance
- Iptacopan
- Manufacturer
- Novartis Europharm Limited
- Country
- Norway (NO)
- ATC code
- L04AJ08
- ATC class
- Iptacopan
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_E7E84F46-3DEC-48A8-A057-0773D240BB37
- no_varenummer55535156NOK 367985.6
- gtin7613421182700
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Iptacopan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFABHALTANovartis Europharm Limited, Dublin
- United StatesFABHALTANovartis Pharmaceuticals Corporation
- SwitzerlandFabhalta
- SpainFABHALTA 200 MG CAPSULAS DURASNovartis Europharm Limited
- FinlandFABHALTANovartis Europharm Limited
- FranceFABHALTA 200 mg, géluleNOVARTIS EUROPHARM (IRLANDE)
- BelgiumFabhalta 200 mgNovartis Europharm
- IrelandFABHALTA 200 mg hard capsulesNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Fabhalta
- Liechtenstein · Fabhalta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfab4ee0-7da2-4a95-9fc2-932f66ab347e GET /v1/drugs/cfab4ee0-7da2-4a95-9fc2-932f66ab347e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsel, hard",
"source": "fest",
"status": "A",
"atc_name": "Iptakopan",
"merkevare_id": "ID_E7E84F46-3DEC-48A8-A057-0773D240BB37",
"name_form_strength": "Fabhalta kaps 200 mg",
"prescription_group": "C"
}See everything about iptacopan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.